China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
中國領導的國家醫療產品管理局12月下旬與浙江華海藥業和石藥集團集團等幾家中國制藥商會面,討論生產仿製藥帕昔洛韋所需的準備工作
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
中國領導的國家醫療產品管理局12月下旬與浙江華海藥業和石藥集團集團等幾家中國制藥商會面,討論生產仿製藥帕昔洛韋所需的準備工作